trial summary · NCT06553651
Necrosectomy With Cryotechnology for Accelerated Removal
Trial record from the TrialBase DB dataset, status RECRUITING, condition Pancreatic Necrosis, sponsored by Christopher C. Thompson, MD, MSc. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
Pancreatic necrosis is a serious complication of acute pancreatitis. Pancreatic necrosis involves the irreversible death of pancreatic tissue, which can lead to severe health issues, including infections and an increased risk of death. An endoscopic procedure called direct endoscopic necrosectomy (DEN) is typically performed to remove this necrotic pancreatic tissue as a minimally invasive treatment. This procedure is performed using a thin, flexible, lighted tube called an endoscope and endoscopic instruments that are used with working channels through the scope. Current methods for removing necrotic tissue involve using endoscopic devices such as snares, baskets, nets, and forceps. However, these standard methods are often not very effective because the necrotic tissue can be sticky and hard to grasp. This DEN procedure is part of regular clinical care to treat this condition and remove necrotic tissue from the pancreas. For this research study, the same DEN procedure will be followed with the exception of the device used for the removal of the necrotic tissue. Instead of using forceps, snares, or other traditional tools, a cryoprobe will be used. Cryoprobes work by using extremely cold temperatures to freeze and adhere to the necrotic tissue, making it easier to remove. This method might be better because it can secure larger tissue samples and potentially reduce complications associated with traditional methods. Cryotechnology is successfully used in endoscopy to remove necrotic tissue, foreign bodies and more, but has not been extensively tested in pancreatic …
Source record: https://clinicaltrials.gov/study/NCT06553651
Facts
| registry id | NCT06553651 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | not reported |
| study type | INTERVENTIONAL |
| lead condition | Pancreatic Necrosis |
| sponsor | Christopher C. Thompson, MD, MSc |
| sponsor class | OTHER |
| enrollment | 20 |
| start date | 2026-12 |
| primary completion | 2028-12 |
| completion | 2029-06 |
| results posted | not reported |
Conditions
- Pancreatic Necrosis
- Acute Pancreatitis
- Acute Pancreatic Necrosis
- Necrosis
- Necrosis Pancreas
- Walled-Off Pancreatic Necrosis
Interventions
- Cryotechnology Necrosectomy Procedure
Countries
- United States
Intervention types: DEVICE
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.